Birdwatch Note
2024-03-28 04:59:32 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ワクチン接種と腎不全の客観的関連に関してはICD9 584の急性腎不全に関して下記の2研究で調べられており 下記のイスラエルの研究でファイザーワクチン接種者はマッチングされた未接種者に比べ接種後一定期間中に有意に急性腎不全リスクが低い一方で(表2),新型コロナ感染者は未感染者に比べ10万人あたり125人の余剰の医療記録の発生があったとされています(図4). https://www.nejm.org/doi/full/10.1056/nejmoa2110475 同様に下記の香港の研究でICD9 584の急性腎不全を含む急性腎障害の医療記録リスクの増価はファイザーワクチン1回目接種2回目接種後とも認められなかった事が報告されています(表3)。 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1773134366165631458
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1773213312119157007
- noteId - 1773213312119157007
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1711601972977
- tweetId - 1773134366165631458
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ワクチン接種と腎不全の客観的関連に関してはICD9 584の急性腎不全に関して下記の2研究で調べられており 下記のイスラエルの研究でファイザーワクチン接種者はマッチングされた未接種者に比べ接種後一定期間中に有意に急性腎不全リスクが低い一方で(表2),新型コロナ感染者は未感染者に比べ10万人あたり125人の余剰の医療記録の発生があったとされています(図4). https://www.nejm.org/doi/full/10.1056/nejmoa2110475 同様に下記の香港の研究でICD9 584の急性腎不全を含む急性腎障害の医療記録リスクの増価はファイザーワクチン1回目接種2回目接種後とも認められなかった事が報告されています(表3)。 https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004018
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-28 04:59:32 UTC (1711601972977) |
2024-03-28 11:46:00 UTC (1711626360336) |
CURRENTLY_RATED_HELPFUL | 2024-03-29 02:46:14 UTC (1711680374764) |
CURRENTLY_RATED_HELPFUL | 2024-03-28 11:46:00 UTC (1711626360336) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-28 19:20:41 -0500 | Rating Details | |
2024-03-28 18:50:22 -0500 | Rating Details | |
2024-03-28 16:50:54 -0500 | Rating Details | |
2024-03-28 15:20:04 -0500 | Rating Details | |
2024-03-28 13:54:59 -0500 | Rating Details | |
2024-03-28 13:06:38 -0500 | Rating Details | |
2024-03-28 12:51:52 -0500 | Rating Details | |
2024-03-28 10:40:54 -0500 | Rating Details | |
2024-03-28 10:36:52 -0500 | Rating Details | |
2024-03-28 10:20:52 -0500 | Rating Details | |
2024-03-28 09:58:52 -0500 | Rating Details | |
2024-03-28 09:02:22 -0500 | Rating Details | |
2024-03-28 08:37:03 -0500 | Rating Details | |
2024-03-28 07:52:24 -0500 | Rating Details | |
2024-03-28 07:46:31 -0500 | Rating Details | |
2024-03-28 07:32:25 -0500 | Rating Details | |
2024-03-28 06:43:33 -0500 | Rating Details | |
2024-03-28 06:28:59 -0500 | Rating Details | |
2024-03-28 06:14:01 -0500 | Rating Details | |
2024-03-28 05:16:46 -0500 | Rating Details | |
2024-03-28 04:33:30 -0500 | Rating Details | |
2024-03-28 03:41:19 -0500 | Rating Details | |
2024-03-28 03:18:54 -0500 | Rating Details | |
2024-03-28 03:11:05 -0500 | Rating Details | |
2024-03-28 03:07:25 -0500 | Rating Details | |
2024-03-28 03:03:16 -0500 | Rating Details | |
2024-03-28 02:51:39 -0500 | Rating Details | |
2024-03-28 02:46:45 -0500 | Rating Details | |
2024-03-28 02:30:29 -0500 | Rating Details | |
2024-03-28 02:15:11 -0500 | Rating Details | |
2024-03-28 02:10:02 -0500 | Rating Details | |
2024-03-28 02:08:19 -0500 | Rating Details | |
2024-03-28 01:57:00 -0500 | Rating Details | |
2024-03-28 01:30:44 -0500 | Rating Details | |
2024-03-28 01:29:41 -0500 | Rating Details | |
2024-03-28 01:23:53 -0500 | Rating Details | |
2024-03-28 01:03:40 -0500 | Rating Details | |
2024-03-28 01:02:13 -0500 | Rating Details | |
2024-03-28 01:01:48 -0500 | Rating Details | |
2024-03-28 00:56:49 -0500 | Rating Details | |
2024-03-28 00:56:46 -0500 | Rating Details | |
2024-03-28 00:54:15 -0500 | Rating Details | |
2024-03-28 00:23:53 -0500 | Rating Details | |
2024-03-28 00:08:55 -0500 | Rating Details | |
2024-03-29 00:43:58 -0500 | Rating Details | |
2024-03-28 17:30:20 -0500 | Rating Details | |
2024-03-28 17:17:56 -0500 | Rating Details | |
2024-03-28 11:10:31 -0500 | Rating Details | |
2024-03-28 10:23:40 -0500 | Rating Details | |
2024-03-28 08:33:17 -0500 | Rating Details | |
2024-03-28 08:03:43 -0500 | Rating Details | |
2024-03-28 07:46:02 -0500 | Rating Details | |
2024-03-28 07:42:59 -0500 | Rating Details | |
2024-03-28 07:38:12 -0500 | Rating Details | |
2024-03-28 07:36:45 -0500 | Rating Details | |
2024-03-28 07:30:18 -0500 | Rating Details | |
2024-03-28 06:49:12 -0500 | Rating Details | |
2024-03-28 05:11:56 -0500 | Rating Details | |
2024-03-28 04:55:23 -0500 | Rating Details | |
2024-03-28 04:23:25 -0500 | Rating Details | |
2024-03-28 03:26:40 -0500 | Rating Details | |
2024-03-28 03:15:13 -0500 | Rating Details | |
2024-03-28 03:14:05 -0500 | Rating Details | |
2024-03-28 03:13:57 -0500 | Rating Details | |
2024-03-28 02:40:17 -0500 | Rating Details | |
2024-03-28 02:35:54 -0500 | Rating Details | |
2024-03-28 02:19:42 -0500 | Rating Details | |
2024-03-28 02:17:27 -0500 | Rating Details | |
2024-03-28 02:12:55 -0500 | Rating Details | |
2024-03-28 01:56:28 -0500 | Rating Details | |
2024-03-28 01:31:39 -0500 | Rating Details | |
2024-03-28 01:30:52 -0500 | Rating Details | |
2024-03-28 01:29:38 -0500 | Rating Details | |
2024-03-28 01:17:23 -0500 | Rating Details | |
2024-03-28 01:09:29 -0500 | Rating Details | |
2024-03-28 01:09:16 -0500 | Rating Details | |
2024-03-28 01:07:58 -0500 | Rating Details | |
2024-03-28 01:06:21 -0500 | Rating Details | |
2024-03-28 01:06:20 -0500 | Rating Details | |
2024-03-28 01:01:54 -0500 | Rating Details | |
2024-03-28 00:59:39 -0500 | Rating Details | |
2024-03-28 00:59:33 -0500 | Rating Details | |
2024-03-28 00:46:46 -0500 | Rating Details | |
2024-03-28 00:41:51 -0500 | Rating Details | |
2024-03-28 00:33:37 -0500 | Rating Details | |
2024-03-28 00:16:37 -0500 | Rating Details | |
2024-03-28 00:03:12 -0500 | Rating Details | |
2024-03-30 13:58:29 -0500 | Rating Details | |
2024-03-30 00:37:06 -0500 | Rating Details | |
2024-03-29 18:44:49 -0500 | Rating Details | |
2024-03-29 16:52:17 -0500 | Rating Details | |
2024-03-29 09:05:45 -0500 | Rating Details | |
2024-03-29 07:18:05 -0500 | Rating Details | |
2024-03-28 22:29:28 -0500 | Rating Details | |
2024-03-28 22:24:36 -0500 | Rating Details | |
2024-03-28 20:29:19 -0500 | Rating Details | |
2024-03-28 17:17:32 -0500 | Rating Details | |
2024-04-09 20:18:47 -0500 | Rating Details | |
2024-03-31 07:18:48 -0500 | Rating Details | |
2024-03-28 22:04:05 -0500 | Rating Details | |
2024-03-29 17:00:42 -0500 | Rating Details | |
2024-03-29 22:33:44 -0500 | Rating Details | |
2024-04-25 05:02:40 -0500 | Rating Details | |
2024-04-20 15:12:30 -0500 | Rating Details | |
2024-04-24 13:02:41 -0500 | Rating Details |